
Rates fell among U.S. men and women from 2019 to 2023, extending a decline lasting more than 20 years.
The CDC says accelerated progress against lung cancer accounted for much of the continued improvement in cancer death rates.
While death rates declined, overall rates of new cancer cases rose slightly each year from 2018 to 2022.
Despite progress, lung cancer remains the second most common cancer among men and women and the leading cause of cancer death nationally.
Increases in breast cancer among women and prostate cancer among men drove overall new-case increases; each is most common in its group.
Prostate cancer rates rose, while overall new-case rates among men remained stable; one cancer type can differ from the broader pattern.
Researchers say sustaining progress may depend on reduced smoking, tobacco-free environments, and access to early detection, timely diagnosis, and treatment.
Read the CDC notice for its full report link, covered time periods, and additional details behind these population-level findings.